Question 1

What is Edesa Biotech Inc (EDSA) stock price today?

Accepted Answer

Edesa Biotech Inc (EDSA) currently trades at $18.28 per share. The stock has a market capitalization of $64.51M and a P/E ratio of —x.

Question 2

Is EDSA stock a buy, sell, or hold in 2026?

Accepted Answer

Based on WallStSmart's proprietary analysis, Edesa Biotech Inc has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

Question 3

What is Edesa Biotech Inc's revenue and earnings?

Accepted Answer

Edesa Biotech Inc has trailing twelve-month (TTM) revenue of $500.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.07.

Question 4

Is EDSA stock overvalued or undervalued?

Accepted Answer

Based on our DCF model, Edesa Biotech Inc's intrinsic value is $0.64, representing a margin of safety of -67.19%. The stock currently trades at a P/E of —x.

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$500.00
Net income	$-17.55M	$-8.37M	$-6.17M	$-7.19M	$-2.25M
EPS	—	—	—	—	$-1.07
Free cash flow	$-12.28M	$-6.64M	$-4.89M	$-7.32M	$-2.09M
Profit margin	—	—	—	—	—

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
EDSA	$64.51M	17	3.7	3.0	4.0	5.0	-67.19%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Edesa Biotech Inc

WallStSmart proprietary scores

Price targets

Price chart

X-Ray snapshot

Key financials

Peer comparison

Smart narrative

Frequently asked questions

Company info

Quick metrics

Performance

Compare